Ra Capital Management, L.P. Solid Biosciences Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $12.8 Million - $25.6 Million	2,391,304 Added 23.97%	12,367,873 $68.4 Million
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $16.6 Million - $42.1 Million	5,405,405 Added 118.25%	9,976,569 $75.6 Million
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $8.15 Million - $21.9 Million	1,881,720 Added 69.97%	4,571,164 $47.3 Million
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $19.3 Million - $89.2 Million	2,689,444 New	2,689,444 $20.2 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.